Document is current
Any future updates will be listed below
-
Authors
Aoki, Yumi http://orcid.org/0000-0002-2674-0707
Tsuboi, Takashi
Furuno, Takehiko
Watanabe, Koichiro
Kayama, Mami
-
Funding
Funding for this research was provided by:
The UNIVERS Foudation (16-02-154)
- License Information
-
More Information
Article History
Received: 18 June 2019
Accepted: 1 July 2020
First Online: 16 July 2020
Ethics approval and consent to participate
: The ethics review board at St. Luke’s International University approved this study (No.15–088). All participants provided written informed consent before their participation in the study.
: Not applicable.
: Author Takashi Tsuboi has received consultant fees from Pfizer and speaker’s honoraria from Tsumura, Eli Lilly, Meiji-Seika Pharma, MSD, Janssen Pharmaceutical, Dainippon Sumitomo Pharma, Mitsubishi Tanabe Pharma, Yoshitomi Yakuhin, Mochida Pharmaceutical, Otsuka Pharmaceutical, Kyowa Pharmaceutical, and Takeda Pharmaceutical. Author Koichiro Watanabe has received manuscript fees or speaker’s honoraria from Astellas Pharma, Daiichi Sankyo, Eli Lilly, GlaxoSmithKline, Janssen Pharmaceutical, Kyowa Pharmaceutical, Meiji Seika Pharma, Mitsubishi Tanabe Pharma, MSD, Otsuka Pharmaceutical, Pfizer, Shionogi, Sumitomo Dainippon Pharma, Takeda Pharmaceutical, and Yoshitomi and has received research/grant support from Astellas Pharma, Daiichi Sankyo, Eisai, MSD, Mitsubishi Tanabe Pharma, Meiji Seika Pharma, Otsuka Pharmaceutical, Pfizer, Shionogi, and Sumitomo Dainippon Pharma and is a consultant of Eisai, Eli Lilly, Kyowa Pharmaceutical, Mitsubishi Tanabe Pharma, Otsuka Pharmaceutical, Pfizer, Sumitomo Dainippon Pharma, Taisho Toyama Pharmaceutical, and Takeda Pharmaceutical. Other authors declare no conflicts of interest.
